Optimizing the therapeutic approach of transurethral alprostadil

Objective To investigate the efficacy and safety of two different starting doses of transurethral alprostadil (250 mu g and 500 mu g, MUSE(R), Vivus Inc., Menlo Park, CA, USA, and Astra Lakemedel A ...